Clinical Trials Explore New Prostate Cancer Therapies
Researchers at NYU Langone’s Perlmutter Cancer Center are investigating two new treatments for prostate cancer.
Clinical Trials Explore New Treatment for Gynecologic Cancer
Clinical trials at NYU Langone’s Perlmutter Cancer Center are testing antibody–drug conjugates as a treatment for gynecologic cancers.
Clinical Trials Focus on Lung Tumor Immunotherapy Response
NYU Langone pulmonologist Dr. Daniel H. Sterman leads new study to boost lung tumor response rate to immunotherapy.
Clinical Trials Important to Cancer Research
Dr. Benjamin G. Neel, director of NYU Langone’s Perlmutter Cancer Center, explains how clinical trials help advance treatment options.
Clinical Trials Led to FDA-Approved Cancer Drugs in 2021
Clinical trials at NYU Langone’s Perlmutter Cancer Center played a role in new drugs approved in 2021 for people with cancer.
Clinical Trials Test Targeted Breast Cancer Treatments
Dr. Nancy Chan, a medical oncologist at NYU Langone’s Perlmutter Cancer Center, leads two clinical trials of targeted breast cancer treatment.
Clinical Wisdom from Steven Abramson, MD
Steven Abramson, MD, chair of NYU Langone’s Department of Medicine, offers insights to first-year students.
Clinician to Lead New Bone Marrow Transplantation Initiative
Hematologist–oncologist Ahmad Samer Al-Homsi will lead a bone marrow transplant program at NYU Langone for treating blood-borne cancers.
Close the Gap Conference Addresses Cancer Care Disparities
NYU Langone’s Perlmutter Cancer Center coproduces conference with SurvivorNet aimed at raising awareness of disparities in cancer care.
Closure of Pittsburgh Coal Plant Tied to Local Health Gains
A study led by NYU Langone researchers found that closing one of Pittsburgh’s biggest coal plants led to declines in air-pollutant emissions.